ClinicalTrials.gg
Not yet recruitingNCT07845175Updated Sep 28, 2026

Gastrointestinal Symptoms in Children With Type 1 Diabetes

An observational study in Type 1 Diabetes Mellitus, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Year to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Assiut University · Observational

How we know

Updated Sep 28, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
254
Ages
1 Year to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Diabetes Mellitus, Type 1 by Assiut University — 7 open to participants now, 7 under way, none of them phase 3. Diabetes Mellitus, Type 1 · Assiut University.

Planned enrollment
Largest of 10
254 · median 115
Started
2026
with 2 others
Observational
10 of 11
6 open now
Registered
11th of 11
by date

Among the 11 studies in Diabetes Mellitus, Type 1 by Assiut University, this one has the largest planned enrollment of the 10 observational ones that give a count, is one of 3 that started in 2026, is one of 10 observational ones, and was the 11th registered.

Diabetes Mellitus, Type 1

3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.

Browse Diabetes Mellitus, Type 1 studies →

Open to participants now

7 of the 11 studies in Diabetes Mellitus, Type 1 by Assiut University are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.

This study: 1 Year to 18 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Diabetes Mellitus, Type 1 by Assiut University, or all of them as a file.
02

Study summary

This cross-sectional study aims to assess the frequency and types of gastrointestinal symptoms in children with type 1 diabetes mellitus compared with age- and sex-matched healthy controls.

Read the detailed description

Gastrointestinal symptoms are relatively common among children with type 1 diabetes mellitus and may affect nutritional status and glycemic control. This observational study will include children aged 1 to 18 years with type 1 diabetes mellitus and age- and sex-matched healthy controls.

Participants will be assessed for the presence and types of gastrointestinal symptoms using a structured history and clinical examination.

03

Conditions studied

  • Type 1 Diabetes Mellitus

Keywords

  • Type 1 diabetes
  • Children
  • Assiut
  • Gastrointestinal symptoms
04

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children and adolescents aged 1-18 years with type 1 diabetes mellitus attending Assiut University Children's Hospital, and age- and sex-matched healthy controls.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Age 1 to 18 years
  • Diagnosis of type 1 diabetes mellitus according to American Diabetes Association criteria (cases)
  • Age- and sex-matched healthy children (controls)
  • Written from parents or legal guardians

Exclusion criteria

Exclusion Criteria:

  • - Diabetes mellitus other than type 1
  • Chronic liver, pancreatic, renal, or neurological disease that may contribute to gastrointestinal symptoms
  • Acute gastrointestinal infection at the time of assessment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
254 participants (estimated)
Patient registry
No

Groups and cohorts

  • Type 1 Diabetes Mellitus

    Children with type 1 diabetes mellitus who will be assessed for gastrointestinal symptoms.

  • Healthy Controls

    Age- and sex-matched healthy children without diabetes who will undergo the same symptom assessment.

06

What researchers measure

Primary outcomes

  1. Prevalence of gastrointestinal symptoms

    Proportion of children with at least one gastrointestinal symptom in the type 1 diabetes group compared with healthy controls.

    Time frame: Baseline

Secondary outcomes

  1. Prevalence of abdominal pain

    Proportion of children reporting abdominal pain.

    Time frame: Baseline

  2. Prevalence of nausea

    Proportion of children reporting nausea.

    Time frame: Baseline

  3. Prevalence of vomiting

    Proportion of children reporting vomiting.

    Time frame: Baseline

  4. Prevalence of constipation

    Proportion of children reporting constipation.

    Time frame: Baseline

  5. Prevalence of diarrhea

    Proportion of children reporting diarrhea.

    Time frame: Baseline

  6. Prevalence of bloating

    Proportion of children reporting bloating.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2026
First posted
Sep 28, 2026
StartEst.
Sep 26, 2026
Primary completionEst.
Sep 26, 2027
CompletionEst.
Feb 20, 2028
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07845175
Lead sponsor
Assiut University
Responsible party
Asmaa Eid Mohammed (Resident Physician, Department of Pediatrics, Assiut University) — Principal investigator
First posted
Sep 28, 2026
Start date
Sep 26, 2026 (estimated)
Primary completion
Sep 26, 2027 (estimated)
Completion
Feb 20, 2028 (estimated)
Last update
Sep 28, 2026

Study contacts

Asmaa E Mohamed, Resident
Contact
Asmaa.18313446@med.aun.edu.eg
+20 10 25714951
Hanaa A Mohammed, prof
study chair · Pediatrics Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion